Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Calabro, Sarah R ^a,b   Maczurek, Annette E ^a,b   Morgan, Alison J ^a,b   Tu, Thomas ^a,b   Wen, Victoria W ^a,b   Yee, Christine ^a,b   Mridha, Auvro ^b   Lee, Maggie ^a,b   D'Avigdor, William ^a,b   Locarnini, Stephen A ^c   McCaughan, Geoffrey W ^a,b,d   Warner, Fiona J ^a,b   McLennan, Susan V ^b,d   Shackel, Nicholas A ^a,b,d  

^a CENTENARY INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Victorian Infectious Disease Research Laboratory   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; CD147 ANTIGEN; COLLAGENASE 3; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; BROMINATED HYDROCARBON; CARBON TETRABROMIDE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER FIBROSIS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ZYMOGRAPHY; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG-INDUCED LIVER INJURY; GENETICS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

ANIMALS; ANTIGENS, CD147; CELLS, CULTURED; DRUG-INDUCED LIVER INJURY; HEPATOCYTES; HUMANS; HYDROCARBONS, BROMINATED; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 84905014875     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090571     Document Type: Article

References (67)

1. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW (2002) Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am J Pathol 160: 641-654. (Pubitemid 34160342)
2. Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115: 209-218. (Pubitemid 40385459)
3. Iredale JP (1997) Tissue inhibitors of metalloproteinases in liver fibrosis. International Journal of Biochemistry and Cell Biology 29: 43-54.
4. Arthur MJ (1990) Matrix degradation in the liver. Semin Liver Dis 10: 47-55.
5. Arthur MJ (1994) Degradation of matrix proteins in liver fibrosis. Pathol Res Pract 190: 825-833.
6. Arthur MJ (1997) Matrix degradation in liver: a role in injury and repair. Hepatology 26: 1069-1071.
7. Arthur MJ (1998) Fibrosis and altered matrix degradation. Digestion 59: 376-380.
8. Hemmann S, Graf J, Roderfeld M, Roeb E (2007) Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 46: 955-975. (Pubitemid 46529049)
9. Veidal SS, Karsdal MA, Vassiliadis E, Nawrocki A, Larsen MR, et al. (2011) MMP mediated degradation of type VI collagen is highly associated with liver fibrosis-identification and validation of a novel biochemical marker assay. PLoS One 6: e24753.
10. Thomas JA, Pope C, Wojtacha D, Robson AJ, Gordon-Walker TT, et al. (2011) Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration and function. Hepatology.
11. Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, et al. (2007) Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 178: 5288-5295. (Pubitemid 46595314)
12. Garciade Leon Mdel C, Montfort I, Tello Montes E, Lopez Vancell R, Olivos Garcia A, et al. (2006) Hepatocyte production of modulators of extracellular liver matrix in normal and cirrhotic rat liver. Exp Mol Pathol 80: 97-108. (Pubitemid 41828233)
13. Garcia-Irigoyen O, Carotti S, Latasa MU, Uriarte I, Fernandez-Barrena MG, et al. (2013) Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair. Liver Int.
14. McLennan SV, Warner FJ, Shackel NA (2012) The role of CD147 in liver injury: "The truth is in the details". J Hepatol.
15. Agrawal SM, Yong VW (2011) The many faces of EMMPRIN - roles in neuroinflammation. Biochim Biophys Acta 1812: 213-219.
16. Toole BP (2003) Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. Current topics in developmental biology 54: 371-389.
17. Yan L, Zucker S, Toole BP (2005) Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thrombosis and Haemostasis 93: 199-204. (Pubitemid 40253722)
18. Guillot S, Delaval P, Brinchault G, Caulet-Maugendre S, Depince A, et al. (2006) Increased extracellular matrix metalloproteinase inducer (EMMPRIN) expression in pulmonary fibrosis. Exp Lung Res 32: 81-97. (Pubitemid 43861131)
19. Wang CH, Dai JY, Wang L, Jia JF, Zheng ZH, et al. (2011) Expression of CD147 (EMMPRIN) on neutrophils in rheumatoid arthritis enhances chemotaxis, matrix metalloproteinase production and invasiveness of synoviocytes. J Cell Mol Med 15: 850-860.
20. Treese C, Mittag A, Lange F, Tarnok A, Loesche A, et al. (2008) Characterization of fibroblasts responsible for cartilage destruction in arthritis. Cytometry A 73: 351-360. (Pubitemid 351522118)
21. Zhu P, Lu N, Shi ZG, Zhou J, Wu ZB, et al. (2006) CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes. Arthritis Res Ther 8: R44.
22. Tomita T, Nakase T, Kaneko M, Shi K, Takahi K, et al. (2002) Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum 46: 373-378. (Pubitemid 34136574)
23. Betsuyaku T, Kadomatsu K, Griffin GL, Muramatsu T, Senior RM (2003) Increased basigin in bleomycin-induced lung injury. Am J Respir Cell Mol Biol 28: 600-606. (Pubitemid 36543407)
24. Zhang DW, Zhao YX, Wei D, Li YL, Zhang Y, et al. (2012) HAb18G/CD147 promotes activation of hepatic stellate cells and is a target for antibody therapy of liver fibrosis. J Hepatol 57: 1283-1291.
25. Howe RC, MacDonald HR (1988) Heterogeneity of immature (Lyt-2-/L3T4-) thymocytes. Identification of four major phenotypically distinct subsets differing in cell cycle status and in vitro activation requirements. J Immunol 140: 1047-1055. (Pubitemid 18088565)
26. Zhang DW, Chen ZN, Bian H (2012) Reply to: "The role of CD147 in liver injury: The truth is in the details". J Hepatol.
27. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW (2001) Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut 49: 565-576. (Pubitemid 32896989)
28. Ikeda M, Sugiyama K, Mizutani T, Tanaka T, Tanaka K, et al. (1998) Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus. Virus Res 56: 157-167. (Pubitemid 28414407)
29. Noguchi M, Hirohashi S (1996) Cell Lines from Non-Neoplastic Liver and Hepatocellular Carcinoma Tissue from a Single Patient. In Vitro Cell and Developmental Biology 32: 135-137.
30. Igakura T, Kadomatsu K, Kaname T, Muramatsu H, Fan QW, et al. (1998) A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis. Dev Biol 194: 152-165. (Pubitemid 28117579)
31. Kuno N, Kadomatsu K, Fan QW, Hagihara M, Senda T, et al. (1998) Female sterility in mice lacking the basigin gene, which encodes a transmembrane glycoprotein belonging to the immunoglobulin superfamily. FEBS Lett 425: 191-194. (Pubitemid 28178887)
32. Shi Z, Wakil AE, Rockey DC (1997) Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci U S A 94: 10663-10668. (Pubitemid 27430791)
33. MacDonald HR, Lees RK, Bron C (1985) Cell surface glycoproteins involved in the stimulation of interleukin 1-dependent interleukin 2 production by a subline of EL4 thymoma cells. I. Functional characterization by monoclonal antibodies. Journal of Immunology 135: 3944-3950. (Pubitemid 16250373)
34. Bertolino P, Trescol-Biemont MC, Rabourdin-Combe C (1998) Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. European journal of immunology 28: 221-236. (Pubitemid 28048293)
35. Itoh Y, Binner S, Nagase H (1995) Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. Biochem J 308 (Pt 2): 645-651.
36. Ogata Y, Itoh Y, Nagase H (1995) Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases. J Biol Chem 270: 18506-18511.
37. Min D, Lyons JG, Jia J, Lo L, McLennan SV (2006) 2-Methoxy-2,4-diphenyl- 3(2H)-furanone-labeled gelatin zymography and reverse zymography: a rapid real-time method for quantification of matrix metalloproteinases-2 and -9 and tissue inhibitors of metalloproteinases. Electrophoresis 27: 357-364. (Pubitemid 43210501)
38. Paizis G, Tikellis C, Cooper ME, Schembri JM, Lew RA, et al. (2005) Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 54: 1790-1796. (Pubitemid 41697680)
39. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, et al. (2002) Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 36: 850-860.
40. Iredale JP (1997) Tissue inhibitors of metalloproteinases in liver fibrosis. Int J Biochem Cell Biol 29: 43-54.
41. Knittel T, Mehde M, Kobold D, Saile B, Dinter C, et al. (1999) Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J Hepatol 30: 48-60. (Pubitemid 29023652)
42. Han YP (2006) Matrix metalloproteinases, the pros and cons, in liver fibrosis. J Gastroenterol Hepatol 21 Suppl 3: S88-91.
43. Tang W, Chang SB, Hemler ME (2004) Links between CD147 function, glycosylation, and caveolin-1. Mol Biol Cell 15: 4043-4050. (Pubitemid 39122010)
44. Serandour AL, Loyer P, Garnier D, Courselaud B, Theret N, et al. (2005) TNFalpha-mediated extracellular matrix remodeling is required for multiple division cycles in rat hepatocytes. Hepatology 41: 478-486. (Pubitemid 40289494)
45. Tang J, Guo YS, Zhang Y, Yu XL, Li L, et al. (2012) CD147 induces UPR to inhibit apoptosis and chemosensitivity by increasing the transcription of Bip in hepatocellular carcinoma. Cell Death Differ 19: 1779-1790.
46. Sawanyawisuth K, Wongkham C, Araki N, Zhao Q, Riggins GJ, et al. (2012) Serial Analysis of Gene Expression Reveals Promising Therapeutic Targets for Liver Fluke-associated Cholangiocarcinoma. Asian Pac J Cancer Prev 13 Suppl: 89-93.
47. Hou Q, Tang X, Liu H, Tang J, Yang Y, et al. (2011) Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147. Cancer Sci 102: 1287-1292.
48. Zhao P, Zhang W, Tang J, Ma XK, Dai JY, et al. (2010) Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer Sci 101: 387-395.
49. Jia L, Xu H, Zhao Y, Jiang L, Yu J, et al. (2008) Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma. Cancer Invest 26: 977-983.
50. Pushkarsky T, Zybarth G, Dubrovsky L, Yurchenko V, Tang H, et al. (2001) CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc Natl Acad Sci U S A 98: 6360-6365. (Pubitemid 32488243)
51. Cho JY, Fox DA, Horejsi V, Sagawa K, Skubitz KM, et al. (2001) The functional interactions between CD98, beta1-integrins, and CD147 in the induction of U937 homotypic aggregation. Blood 98: 374-382.
52. Joseph J, Knobler RL, Lublin FD, Burns FR (1993) Regulation of the expression of intercellular adhesion molecule-1 (ICAM-1) and the putative adhesion molecule Basigin on murine cerebral endothelial cells by MHV-4 (JHM). Adv Exp Med Biol 342: 389-391.
53. Kasinrerk W, Tokrasinwit N, Phunpae P (1999) CD147 monoclonal antibodies induce homotypic cell aggregation of monocytic cell line U937 via LFA-1/ICAM-1 pathway. Immunology 96: 184-192. (Pubitemid 29064327)
54. Xu Q, Cao JS, Zhang XM (2002) Liver-infiltrating T lymphocytes cause hepatocyte damage by releasing humoral factors via LFA-1/ICAM-1 interaction in immunological liver injury. Inflamm Res 51: 44-50. (Pubitemid 34117372)
55. Matsumoto G, Tsunematsu S, Tsukinoki K, Ohmi Y, Iwamiya M, et al. (2002) Essential role of the adhesion receptor LFA-1 for T cell-dependent fulminant hepatitis. J Immunol 169: 7087-7096. (Pubitemid 36899297)
56. Ohteki T, Maki C, Koyasu S, Mak TW, Ohashi PS (1999) Cutting edge: LFA-1 is required for liver NK1.1+TCR alpha beta+ cell development: evidence that liver NK1.1 +TCR alpha beta+ cells originate from multiple pathways. J Immunol 162: 3753-3756. (Pubitemid 29314748)
57. Bataller R, Gabele E, Parsons CJ, Morris T, Yang L, et al. (2005) Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. Hepatology 41: 1046-1055. (Pubitemid 40593912)
58. Hamzavi J, Ehnert S, Godoy P, Ciuclan L, Weng H, et al. (2008) Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice. J Cell Mol Med 12: 2130-2144.
59. Haruyama T, Ajioka I, Akaike T, Watanabe Y (2000) Regulation and significance of hepatocyte-derived matrix metalloproteinases in liver remodeling. Biochem Biophys Res Commun 272: 681-686. (Pubitemid 30420698)
60. Watanabe T, Niioka M, Ishikawa A, Hozawa S, Arai M, et al. (2001) Dynamic change of cells expressing MMP-2 mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat. J Hepatol 35: 465-473. (Pubitemid 32964445)
61. Pinzani M, Rombouts K (2004) Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 36: 231-242. (Pubitemid 41115470)
62. Uchinami H, Seki E, Brenner DA, D'Armiento J (2006) Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology 44: 420-429. (Pubitemid 44214881)
63. Henkel C, Roderfeld M, Weiskirchen R, Scheibe B, Matern S, et al. (2005) Identification of fibrosis-relevant proteins using DIGE (difference in gel electrophoresis) in different models of hepatic fibrosis. Z Gastroenterol 43: 23-29. (Pubitemid 40175388)
64. Roeb E, Bosserhoff AK, Hamacher S, Jansen B, Dahmen J, et al. (2005) Enhanced migration of tissue inhibitor of metalloproteinase overexpressing hepatoma cells is attributed to gelatinases: relevance to intracellular signaling pathways. World J Gastroenterol 11: 1096-1104. (Pubitemid 40352993)
65. Iredale JP, Thompson A, Henderson NC (2013) Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation. Biochim Biophys Acta 1832: 876-883.
66. Egawa N, Koshikawa N, Tomari T, Nabeshima K, Isobe T, et al. (2006) Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells. J Biol Chem 281: 37576-37585. (Pubitemid 46042061)
67. Tang Y, Kesavan P, Nakada MT, Yan L (2004) Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2: 73-80. (Pubitemid 38250423)